Chae Min Suk, Lee Kyung Kwan, Jeong Jin-Oh, Jeong Wonwoo, Moon Young Wook, Min Ji Young
Department of Anesthesiology and Pain Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Life (Basel). 2025 Apr 23;15(5):687. doi: 10.3390/life15050687.
Effective postoperative pain management is crucial for optimizing recovery and clinical outcomes in living donor kidney transplantation (LDKT). This retrospective study compared the efficacy and safety of transversus abdominis plane (TAP) block and local wound infiltration (LWI) for postoperative analgesia. A total of 524 LDKT recipients, matched through propensity scoring, were analyzed (262 per group). Pain intensity was assessed using the visual analog scale (VAS) at multiple postoperative time points, while opioid consumption was evaluated based on intravenous patient-controlled analgesia (IV-PCA) usage and rescue fentanyl doses. The TAP block group had significantly lower VAS pain scores at 1, 4, and 8 h postoperatively ( < 0.001) and required fewer opioids, as evidenced by reduced IV-PCA usage (55.9 ± 10.2 mL vs. 69.7 ± 18.2 mL; < 0.001) and lower rescue fentanyl doses (67.7 ± 30.6 µg vs. 119.1 ± 71.8 µg; < 0.001). Despite these differences in analgesic efficacy, no significant differences were observed between the groups in terms of postoperative nausea and vomiting or complications such as systemic toxicity and nerve injury. These findings suggest that the TAP block provides more effective early postoperative pain relief and reduces opioid requirements without increasing adverse events. Given its favorable safety profile and effectiveness, the TAP block is a valuable component of multimodal analgesia in LDKT recipients, supporting enhanced recovery while minimizing opioid-related complications.
有效的术后疼痛管理对于优化活体供肾移植(LDKT)的恢复和临床结局至关重要。这项回顾性研究比较了腹横肌平面(TAP)阻滞和局部伤口浸润(LWI)用于术后镇痛的疗效和安全性。通过倾向评分匹配的524例LDKT受者被纳入分析(每组262例)。在术后多个时间点使用视觉模拟量表(VAS)评估疼痛强度,同时根据静脉自控镇痛(IV-PCA)的使用情况和急救芬太尼剂量评估阿片类药物的消耗量。TAP阻滞组术后1、4和8小时的VAS疼痛评分显著更低(<0.001),且所需阿片类药物更少,IV-PCA使用量减少(55.9±10.2 mL对69.7±18.2 mL;<0.001)以及急救芬太尼剂量更低(67.7±30.6 μg对119.1±71.8 μg;<0.001)均证明了这一点。尽管在镇痛效果上存在这些差异,但两组在术后恶心呕吐或全身毒性和神经损伤等并发症方面未观察到显著差异。这些发现表明,TAP阻滞可提供更有效的术后早期疼痛缓解并减少阿片类药物需求,且不增加不良事件。鉴于其良好的安全性和有效性,TAP阻滞是LDKT受者多模式镇痛的重要组成部分,有助于促进恢复同时将阿片类药物相关并发症降至最低。